Live Breaking News & Updates on Risk Factor In Accustem Sciences Inc

Stay updated with breaking news from Risk factor in accustem sciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AccuStem Sciences, Inc.: AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer

LONDON and PHOENIX, May 02, 2023 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today ....

United States , City Of , United Kingdom , Wendy Blosser , Jeff Fensterer , Risk Factor In Accustem Sciences Inc , Trademark Office , Exchange Commission , Accustem Sciences Inc , Stem Sciences , Chief Executive Officer , Risk Factor , Accustem Sciences , Annual Report , Chief Operations , Chief Executive ,

AccuStem Sciences, Inc.: AccuStem Announces Adjournment of Annual Meeting of Stockholders

LONDON and PHOENIX, Oct. 10, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today ....

United States , City Of , United Kingdom , Wendy Blosser , Jeff Fensterer , Exchange Commission , Accustem Sciences Inc , Exchange Commission On , Risk Factor In Accustem Sciences Inc , Stem Sciences , Annual Meeting , Risk Factor , Accustem Sciences , Annual Report , Chief Operations , Chief Executive ,

AccuStem Sciences, Inc.: AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer

LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced ....

United States , City Of , United Kingdom , Wendy Blosser , Jeff Fensterer , Exchange Commission , Trademark Office , Accustem Sciences Inc , Risk Factor In Accustem Sciences Inc , Stem Sciences , Kits Comprising Gene Signatures , Stratifying Breast Cancer Patients , Chief Executive Officer , Risk Factor , Accustem Sciences , Annual Report , Chief Operations , Chief Executive ,